Copyright Reports & Markets. All rights reserved.

USA Artificial Pancreas Devices System Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Artificial Pancreas Devices System Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Threshold Suspend Device System Market Performance (Volume)
      • 2.1.2 Non-Threshold Suspend Device System (NTSDS) Market Performance (Volume)
      • 2.1.3 Control To Range System (CTRS) Market Performance (Volume)
      • 2.1.4 Control To Target System (CTTS) Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Threshold Suspend Device System Market Performance (Value)
      • 2.1.2 Non-Threshold Suspend Device System (NTSDS) Market Performance (Value)
      • 2.1.3 Control To Range System (CTRS) Market Performance (Value)
      • 2.1.4 Control To Target System (CTTS) Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospital Market Performance (Volume)
      • 3.1.2 Clinic Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Medtronic
      • 4.1.1 Medtronic Profiles
      • 4.1.2 Medtronic Product Information
      • 4.1.3 Medtronic Artificial Pancreas Devices System Business Performance
      • 4.1.4 Medtronic Artificial Pancreas Devices System Business Development and Market Status
    • 4.2 Johnson & Johnson
      • 4.2.1 Johnson & Johnson Profiles
      • 4.2.2 Johnson & Johnson Product Information
      • 4.2.3 Johnson & Johnson Artificial Pancreas Devices System Business Performance
      • 4.2.4 Johnson & Johnson Artificial Pancreas Devices System Business Development and Market Status
    • 4.3 Insulet
      • 4.3.1 Insulet Profiles
      • 4.3.2 Insulet Product Information
      • 4.3.3 Insulet Artificial Pancreas Devices System Business Performance
      • 4.3.4 Insulet Artificial Pancreas Devices System Business Development and Market Status
    • 4.4 Tandem Diabetes Care
      • 4.4.1 Tandem Diabetes Care Profiles
      • 4.4.2 Tandem Diabetes Care Product Information
      • 4.4.3 Tandem Diabetes Care Artificial Pancreas Devices System Business Performance
      • 4.4.4 Tandem Diabetes Care Artificial Pancreas Devices System Business Development and Market Status
    • 4.5 Roche
      • 4.5.1 Roche Profiles
      • 4.5.2 Roche Product Information
      • 4.5.3 Roche Artificial Pancreas Devices System Business Performance
      • 4.5.4 Roche Artificial Pancreas Devices System Business Development and Market Status
    • 4.6 Beta Bionics
      • 4.6.1 Beta Bionics Profiles
      • 4.6.2 Beta Bionics Product Information
      • 4.6.3 Beta Bionics Artificial Pancreas Devices System Business Performance
      • 4.6.4 Beta Bionics Artificial Pancreas Devices System Business Development and Market Status
    • 4.7 Bigfoot Biomedical
      • 4.7.1 Bigfoot Biomedical Profiles
      • 4.7.2 Bigfoot Biomedical Product Information
      • 4.7.3 Bigfoot Biomedical Artificial Pancreas Devices System Business Performance
      • 4.7.4 Bigfoot Biomedical Artificial Pancreas Devices System Business Development and Market Status
    • 4.8 Cellnovo
      • 4.8.1 Cellnovo Profiles
      • 4.8.2 Cellnovo Product Information
      • 4.8.3 Cellnovo Artificial Pancreas Devices System Business Performance
      • 4.8.4 Cellnovo Artificial Pancreas Devices System Business Development and Market Status
    • 4.9 Dexcom
      • 4.9.1 Dexcom Profiles
      • 4.9.2 Dexcom Product Information
      • 4.9.3 Dexcom Artificial Pancreas Devices System Business Performance
      • 4.9.4 Dexcom Artificial Pancreas Devices System Business Development and Market Status
    • 4.10 Dose Safety
      • 4.10.1 Dose Safety Profiles
      • 4.10.2 Dose Safety Product Information
      • 4.10.3 Dose Safety Artificial Pancreas Devices System Business Performance
      • 4.10.4 Dose Safety Artificial Pancreas Devices System Business Development and Market Status
    • 4.11 DreaMed Diabetes
    • 4.12 Inreda Diabetic
    • 4.13 Insulet

    5 Market Performance for Manufacturers

    • 5.1 USA Artificial Pancreas Devices System Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 USA Artificial Pancreas Devices System Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 USA Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 USA Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Northeast Market Performance for Manufacturers
      • 6.1.1 Northeast Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Northeast Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Northeast Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Northeast Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Midwest Market Performance for Manufacturers
      • 6.2.1 Midwest Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Midwest Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Midwest Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Midwest Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Market Performance for Manufacturers
      • 6.3.1 South Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 West Market Performance for Manufacturers
      • 6.4.1 West Artificial Pancreas Devices System Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 West Artificial Pancreas Devices System Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 West Artificial Pancreas Devices System Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 West Artificial Pancreas Devices System Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration

    7 USA Artificial Pancreas Devices System Market Performance (Sales Point)

    • 7.1 USA Artificial Pancreas Devices System Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 USA Artificial Pancreas Devices System Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 USA Artificial Pancreas Devices System Price (USD/Unit) by Regions 2013-2018
    • 7.4 USA Artificial Pancreas Devices System Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 USA Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Northeast Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Midwest Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 West Artificial Pancreas Devices System Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospital Industry
    • 11.2 Clinic Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 USA Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 USA Artificial Pancreas Devices System Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Northeast Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Midwest Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 West Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Artificial Pancreas Devices System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Threshold Suspend Device System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Non-Threshold Suspend Device System (NTSDS) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Control To Range System (CTRS) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 Control To Target System (CTTS) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Hospital Sales and and Growth Rate 2019-2024
      • 12.4.3 Clinic Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 USA Artificial Pancreas Devices System Price (USD/Unit) Trend 2019-2024
      • 12.5.2 USA Artificial Pancreas Devices System Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Artificial Pancreas Devices System for these regions, from 2012 to 2023 (forecast), including
    Northeast
    Midwest
    South
    West

    USA Artificial Pancreas Devices System market competition by top manufacturers/players, with Artificial Pancreas Devices System sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Medtronic
    Johnson & Johnson
    Insulet
    Tandem Diabetes Care
    Roche
    Beta Bionics
    Bigfoot Biomedical
    Cellnovo
    Dexcom
    Dose Safety
    DreaMed Diabetes
    Inreda Diabetic
    Type Zero Technologies

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Threshold Suspend Device System
    Non-Threshold Suspend Device System (NTSDS)
    Control To Range System (CTRS)
    Control To Target System (CTTS)

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Artificial Pancreas Devices System for each application, including
    Hospital
    Clinic

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now